ID

32908

Description

Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT00885378

Lien

https://clinicaltrials.gov/show/NCT00885378

Mots-clés

  1. 19/11/2018 19/11/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

19 novembre 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Type 2 Diabetes Mellitus NCT00885378

Eligibility Type 2 Diabetes Mellitus NCT00885378

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes
Description

Diabetes Mellitus, Non-Insulin-Dependent

Type de données

boolean

Alias
UMLS CUI [1]
C0011860
18-78 years of age
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
taking stable twice daily (bid) dosing of metformin ir (at least 1500 mg) for at least 8 weeks
Description

Metformin Immediate Release | Dose Stable U/day

Type de données

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C1708470
UMLS CUI [2,1]
C0178602
UMLS CUI [2,2]
C0205360
UMLS CUI [2,3]
C0456683
a1c: 7-10%
Description

Hemoglobin A1c measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0474680
c-peptide: ≥ 0.8 ng/ml
Description

C-peptide measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0202100
body mass index (bmi): ≤45 kg/m^2
Description

Body mass index

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
women of childbearing potential unable or unwilling to use acceptable birth control
Description

Childbearing Potential Contraceptive methods Unable | Childbearing Potential Contraceptive methods Unwilling

Type de données

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C1299582
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C0558080
women who are pregnant or breastfeeding
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
fasting plasma glucose (fpg) >270 mg/dl
Description

Plasma fasting glucose measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0583513
significant cardiovascular history
Description

Cardiovascular History

Type de données

boolean

Alias
UMLS CUI [1]
C1880008
symptoms of poorly controlled diabetes
Description

Symptoms Poorly controlled diabetes mellitus

Type de données

boolean

Alias
UMLS CUI [1,1]
C1457887
UMLS CUI [1,2]
C0554876
history of diabetic ketoacidosis or hyperosmolar nonketotic coma
Description

Diabetic Ketoacidosis | Hyperosmolar Nonketotic Coma

Type de données

boolean

Alias
UMLS CUI [1]
C0011880
UMLS CUI [2]
C0020457
insulin therapy within one year of screening
Description

Insulin regime

Type de données

boolean

Alias
UMLS CUI [1]
C0557978
cardiovascular even within the prior 6 months
Description

Cardiovascular Disease

Type de données

boolean

Alias
UMLS CUI [1]
C0007222
new york heart association stage iii/iv congestive heart failure and/or known left ventricular ejection fraction <=40%
Description

Congestive heart failure New York Heart Association Classification | Left ventricular ejection fraction

Type de données

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C1275491
UMLS CUI [2]
C0428772
significant history of renal or hepatic disease
Description

Kidney Disease | Liver disease

Type de données

boolean

Alias
UMLS CUI [1]
C0022658
UMLS CUI [2]
C0023895
history of a psychiatric disorder, alcohol or drug abuse within the previous year
Description

Mental disorders | Substance Use Disorders

Type de données

boolean

Alias
UMLS CUI [1]
C0004936
UMLS CUI [2]
C0038586
treatment with potent cyp3a4 inhibitors or inducers
Description

CYP3A4 Inhibitor | CYP3A4 Inducer

Type de données

boolean

Alias
UMLS CUI [1]
C3830624
UMLS CUI [2]
C3830625
immunocompromised participants
Description

Immunocompromised patient

Type de données

boolean

Alias
UMLS CUI [1]
C0085393
active liver disease or clinically significant abnormal hepatic, renal , endocrine, metabolic, or hematological screening tests
Description

Liver disease | Screening test Hepatic Abnormal | Screening test Renal Abnormal | Screening test Endocrine Abnormal | Screening test Metabolic Abnormal | Screening test Hematologic Abnormal

Type de données

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2,1]
C0871311
UMLS CUI [2,2]
C0205054
UMLS CUI [2,3]
C0205161
UMLS CUI [3,1]
C0871311
UMLS CUI [3,2]
C0022646
UMLS CUI [3,3]
C0205161
UMLS CUI [4,1]
C0871311
UMLS CUI [4,2]
C0014136
UMLS CUI [4,3]
C0205161
UMLS CUI [5,1]
C0871311
UMLS CUI [5,2]
C0311400
UMLS CUI [5,3]
C0205161
UMLS CUI [6,1]
C0871311
UMLS CUI [6,2]
C0205488
UMLS CUI [6,3]
C0205161

Similar models

Eligibility Type 2 Diabetes Mellitus NCT00885378

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Age
Item
18-78 years of age
boolean
C0001779 (UMLS CUI [1])
Metformin Immediate Release | Dose Stable U/day
Item
taking stable twice daily (bid) dosing of metformin ir (at least 1500 mg) for at least 8 weeks
boolean
C0025598 (UMLS CUI [1,1])
C1708470 (UMLS CUI [1,2])
C0178602 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0456683 (UMLS CUI [2,3])
Hemoglobin A1c measurement
Item
a1c: 7-10%
boolean
C0474680 (UMLS CUI [1])
C-peptide measurement
Item
c-peptide: ≥ 0.8 ng/ml
boolean
C0202100 (UMLS CUI [1])
Body mass index
Item
body mass index (bmi): ≤45 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Childbearing Potential Contraceptive methods Unable | Childbearing Potential Contraceptive methods Unwilling
Item
women of childbearing potential unable or unwilling to use acceptable birth control
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0558080 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
women who are pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Plasma fasting glucose measurement
Item
fasting plasma glucose (fpg) >270 mg/dl
boolean
C0583513 (UMLS CUI [1])
Cardiovascular History
Item
significant cardiovascular history
boolean
C1880008 (UMLS CUI [1])
Symptoms Poorly controlled diabetes mellitus
Item
symptoms of poorly controlled diabetes
boolean
C1457887 (UMLS CUI [1,1])
C0554876 (UMLS CUI [1,2])
Diabetic Ketoacidosis | Hyperosmolar Nonketotic Coma
Item
history of diabetic ketoacidosis or hyperosmolar nonketotic coma
boolean
C0011880 (UMLS CUI [1])
C0020457 (UMLS CUI [2])
Insulin regime
Item
insulin therapy within one year of screening
boolean
C0557978 (UMLS CUI [1])
Cardiovascular Disease
Item
cardiovascular even within the prior 6 months
boolean
C0007222 (UMLS CUI [1])
Congestive heart failure New York Heart Association Classification | Left ventricular ejection fraction
Item
new york heart association stage iii/iv congestive heart failure and/or known left ventricular ejection fraction <=40%
boolean
C0018802 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
C0428772 (UMLS CUI [2])
Kidney Disease | Liver disease
Item
significant history of renal or hepatic disease
boolean
C0022658 (UMLS CUI [1])
C0023895 (UMLS CUI [2])
Mental disorders | Substance Use Disorders
Item
history of a psychiatric disorder, alcohol or drug abuse within the previous year
boolean
C0004936 (UMLS CUI [1])
C0038586 (UMLS CUI [2])
CYP3A4 Inhibitor | CYP3A4 Inducer
Item
treatment with potent cyp3a4 inhibitors or inducers
boolean
C3830624 (UMLS CUI [1])
C3830625 (UMLS CUI [2])
Immunocompromised patient
Item
immunocompromised participants
boolean
C0085393 (UMLS CUI [1])
Liver disease | Screening test Hepatic Abnormal | Screening test Renal Abnormal | Screening test Endocrine Abnormal | Screening test Metabolic Abnormal | Screening test Hematologic Abnormal
Item
active liver disease or clinically significant abnormal hepatic, renal , endocrine, metabolic, or hematological screening tests
boolean
C0023895 (UMLS CUI [1])
C0871311 (UMLS CUI [2,1])
C0205054 (UMLS CUI [2,2])
C0205161 (UMLS CUI [2,3])
C0871311 (UMLS CUI [3,1])
C0022646 (UMLS CUI [3,2])
C0205161 (UMLS CUI [3,3])
C0871311 (UMLS CUI [4,1])
C0014136 (UMLS CUI [4,2])
C0205161 (UMLS CUI [4,3])
C0871311 (UMLS CUI [5,1])
C0311400 (UMLS CUI [5,2])
C0205161 (UMLS CUI [5,3])
C0871311 (UMLS CUI [6,1])
C0205488 (UMLS CUI [6,2])
C0205161 (UMLS CUI [6,3])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial